reglab/housing_qa huggingface dataset:
MT Code § 50-32-230 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-230. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV

  50-32-230. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV. The board may except by rule any compound, mixture, or preparation containing any depressant drug listed in 50-32-229 from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the drugs which have a depressant effect on the central nervous system.   History: En. Sec. 11, Ch. 412, L. 1973; R.C.M. 1947, 54-311(3).
MT Code § 50-32-231 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-231. Criteria for placement of drug in Schedule V

  50-32-231. Criteria for placement of drug in Schedule V. The board shall place a drug in Schedule V if it finds that:   (1) the drug has low potential for abuse relative to the controlled drugs listed in Schedule IV;   (2) the drug has currently accepted medical use in treatment in the United States; and   (3) the drug has limited physical dependence or psychological dependence liability relative to the dangerous drugs listed in Schedule IV.   History: En. Sec. 12, Ch. 412, L. 1973; R.C.M. 1947, 54-312.
MT Code § 50-32-232 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-232. Specific dangerous drugs included in Schedule V

  50-32-232. Specific dangerous drugs included in Schedule V. Schedule V consists of the drugs and other substances, by whatever official, common, usual, chemical, or brand name designated, listed in this section.   (1) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following is a narcotic drug, including its salts, calculated as the free anhydrous base or alkaloid in limited quantities as set forth in subsections (1)(a) through (1)(f), which include one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:   (a) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;   (b) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;   (c) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;   (d) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;   (e) not more than 100 milligrams of opium per 100 milliliters or per 100 grams; and   (f) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.   (2) Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of pyrovalerone is a stimulant having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.   (3) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances is a depressant having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:   (a) lacosamide, also known as (R)-2-acetoamido-N-benzyl-3-methoxy-propionamide or vimpat; and   (b) pregabalin, also known as (S)-3-(aminomethyl)-5-methylhexanoic acid or lyrica.   (4) Approved cannabidiol drugs. A drug product in finished dosage formulation that has been approved by the United States food and drug administration that contains cannabidiol, also known as (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol), derived from cannabis and no more than 0.1% (w/w) residual tetrahydrocannabinols.   (5) Anticonvulsant substances include the following:   (a) ezogabine; and   (b) brivaracetam.   History: En. Sec. 13, Ch. 412, L. 1973; R.C.M. 1947, 54-313; amd. Sec. 15, Ch. 37, L. 1979; amd. Sec. 5, Ch. 141, L. 1983; amd. Sec. 5, Ch. 36, L. 1991; amd. Sec. 6, Ch. 113, L. 1997; amd. Sec. 2, Ch. 108, L. 2007; amd. Sec. 10, Ch. 135, L. 2013; amd. Sec. 5, Ch. 134, L. 2019.
MT Code § 50-32-233 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-233. Exempt anabolic steroid products

  50-32-233. Exempt anabolic steroid products. The following anabolic steroid-containing compounds, mixtures, or preparations are exempt from this chapter:   (1) androgyn L.A.;   (2) andro-estro 90-4;   (3) depandrogyn;   (4) DEPO-T.E.;   (5) deptestrogen;   (6) duomone;   (7) duratestrin;   (8) duo-span II;   (9) estratest;   (10) estratest HS;   (11) pan estra test;   (12) premarin with methyltestosterone;   (13) synovex H pellets in process;   (14) synovex H pellets in process granulation;   (15) test-estro cypionates;   (16) testagen;   (17) testosterone cyp 50 estradiol cyp 2;   (18) testosterone, cypionate-estradiol, cypionate injection;   (19) testosterone, enanthate-estradiol, valerate injection; and   (20) tilapia sex reversal feed (investigational).   History: En. Sec. 7, Ch. 113, L. 1997.
MT Code § 50-32-301 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-301. Annual registration required for manufacturer, distributor, or dispenser

  50-32-301. Annual registration required for manufacturer, distributor, or dispenser. (1) Every person who manufactures, distributes, or dispenses any dangerous drug within this state must obtain annually a registration issued by the department in accordance with board rules.   (2) Persons registered by the board under this chapter to manufacture, distribute, dispense, or conduct research with dangerous drugs may possess, manufacture, distribute, dispense, or conduct research with those drugs to the extent authorized by their registration and in conformity with the other provisions of this chapter.   History: En. Sec. 16, Ch. 412, L. 1973; amd. Sec. 6, Ch. 350, L. 1974; amd. Sec. 1, Ch. 291, L. 1975; R.C.M. 1947, 54-316(1), (2); amd. Sec. 15, Ch. 379, L. 1981.
MT Code § 50-32-302 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-302. Exceptions to registration requirement

  50-32-302. Exceptions to registration requirement. The following persons need not register and may lawfully possess dangerous drugs under this chapter:   (1) an agent or employee of any registered manufacturer, distributor, or dispenser of any dangerous drug if the agent or employee is acting in the usual course of business or employment;   (2) a common or contract carrier or warehouse operator or an employee of the carrier or warehouse operator, whose possession of any dangerous drug is in the usual course of business or employment;   (3) an ultimate user or a person in possession of any dangerous drug pursuant to a lawful order of a practitioner or in lawful possession of a Schedule V drug;   (4) officers and employees of the state, or a political subdivision of the state while acting in the course of their official duties.   History: En. Sec. 16, Ch. 412, L. 1973; amd. Sec. 6, Ch. 350, L. 1974; amd. Sec. 1, Ch. 291, L. 1975; R.C.M. 1947, 54-316(3); amd. Sec. 1846, Ch. 56, L. 2009.
MT Code § 50-32-303 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-303. Waiver of registration requirement for practitioners licensed by federal government

  50-32-303. Waiver of registration requirement for practitioners licensed by federal government. The board shall waive the requirement for registration of practitioners, other than pharmacies, who are registered or licensed by the federal government to dispense dangerous drugs.   History: En. Sec. 16, Ch. 412, L. 1973; amd. Sec. 6, Ch. 350, L. 1974; amd. Sec. 1, Ch. 291, L. 1975; R.C.M. 1947, 54-316(4).
MT Code § 50-32-304 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-304. Waiver of registration requirement when in public interest

  50-32-304. Waiver of registration requirement when in public interest. The board may waive by rule the requirement for registration of certain manufacturers, distributors, or dispensers if it finds it consistent with the public health and safety.   History: En. Sec. 16, Ch. 412, L. 1973; amd. Sec. 6, Ch. 350, L. 1974; amd. Sec. 1, Ch. 291, L. 1975; R.C.M. 1947, 54-316(5).
MT Code § 50-32-305 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-305. Separate registration required

  50-32-305. Separate registration required. A separate registration is required at each principal place of business or professional practice where the applicant manufactures, distributes, or dispenses dangerous drugs.   History: En. Sec. 16, Ch. 412, L. 1973; amd. Sec. 6, Ch. 350, L. 1974; amd. Sec. 1, Ch. 291, L. 1975; R.C.M. 1947, 54-316(6).
MT Code § 50-32-306 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-306. Criteria for registration of manufacturers and distributors

  50-32-306. Criteria for registration of manufacturers and distributors. (1) The board shall register an applicant to manufacture or distribute dangerous drugs included in 50-32-222, 50-32-224, 50-32-226, 50-32-229, and 50-32-232 unless it determines that the issuance of that registration would be inconsistent with the public interest.   (2) In determining the public interest, the board shall consider the following factors:   (a) maintenance of effective controls against diversion of dangerous drugs into other than legitimate medical, scientific, or industrial channels;   (b) compliance with applicable state and local law;   (c) any convictions of the applicant under any federal and state laws relating to any dangerous drug;   (d) past experience in the manufacture or distribution of dangerous drugs and the existence in the applicant's establishment of effective controls against diversion;   (e) furnishing by the applicant of false or fraudulent material in any application filed under this chapter;   (f) suspension or revocation of the applicant's federal registration to manufacture, distribute, or dispense dangerous drugs as authorized by federal law; and   (g) any other factors relevant to and consistent with the public health and safety.   (3) Compliance by manufacturers and distributors with the provisions of the federal law respecting registration (excluding fees) entitles them to be registered under this chapter.   History: En. Sec. 17, Ch. 412, L. 1973; amd. Sec. 7, Ch. 350, L. 1974; R.C.M. 1947, 54-317(1), (4).
MT Code § 50-32-307 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-307. Manufacture and distribution limited by registration

  50-32-307. Manufacture and distribution limited by registration. Registration under 50-32-306 does not entitle a registrant to manufacture and distribute dangerous drugs in Schedule I or II other than those specified in the registration.   History: En. Sec. 17, Ch. 412, L. 1973; amd. Sec. 7, Ch. 350, L. 1974; R.C.M. 1947, 54-317(2).
MT Code § 50-32-308 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-308. Criteria for registration of practitioners

  50-32-308. Criteria for registration of practitioners. (1) Practitioners shall be registered to dispense any dangerous drugs or to conduct research with dangerous drugs in Schedules II through V if they are authorized to dispense or conduct research under the laws of this state. The board need not require separate registration for practitioners engaging in research with nonnarcotic dangerous drugs in Schedules II through V where the registrant is already registered under this chapter in another capacity.   (2) Practitioners registered under federal law to conduct research with Schedule I drugs may conduct research with Schedule I drugs within this state upon furnishing the board evidence of that federal registration.   History: En. Sec. 17, Ch. 412, L. 1973; amd. Sec. 7, Ch. 350, L. 1974; R.C.M. 1947, 54-317(3).
MT Code § 50-32-309 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-309. Registrants to maintain records and inventories

  50-32-309. Registrants to maintain records and inventories. Persons registered to manufacture, distribute, or dispense dangerous drugs under this chapter shall keep records and maintain inventories in conformance with the recordkeeping and inventory requirements of federal law and with any additional rules the board issues.   History: En. Sec. 20, Ch. 412, L. 1973; R.C.M. 1947, 54-320.
MT Code § 50-32-310 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-310. Inspections authorized

  50-32-310. Inspections authorized. The board may have the establishment of a registrant or applicant for registration inspected.   History: En. Sec. 16, Ch. 412, L. 1973; amd. Sec. 6, Ch. 350, L. 1974; amd. Sec. 1, Ch. 291, L. 1975; R.C.M. 1947, 54-316(7).
MT Code § 50-32-311 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-311. Revocation or suspension of registration

  50-32-311. Revocation or suspension of registration. (1) A registration under 50-32-301 to manufacture, distribute, or dispense a dangerous drug may be suspended or revoked by the board upon a finding that the registrant has:   (a) furnished false or fraudulent material information in any application filed under this chapter;   (b) been convicted of a felony under any state or federal law relating to any dangerous drug or controlled substance; or   (c) had the registrant's federal registration suspended or revoked to manufacture, distribute, or dispense controlled substances.   (2) The board may limit revocation or suspension of a registration to the particular dangerous drug with respect to which grounds for revocation or suspension exist.   (3) If the board suspends or revokes a registration, all dangerous drugs owned or possessed by the registrant at the time of suspension or the effective date of the revocation order may be placed under seal. A disposition may not be made of drugs under seal until the time for taking an appeal has elapsed or until all appeals have been concluded unless a court, upon application, orders the sale of perishable drugs and the deposit of the proceeds of the sale with the court. Upon a revocation order becoming final, all dangerous drugs may be forfeited to the state.   (4) The board shall promptly cause the bureau to be notified of all orders suspending or revoking registration and all forfeitures of dangerous drugs.   History: En. Sec. 18, Ch. 412, L. 1973; amd. Sec. 8, Ch. 350, L. 1974; R.C.M. 1947, 54-318; amd. Sec. 1847, Ch. 56, L. 2009.
MT Code § 50-32-312 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-312. Procedure for denial, suspension, revocation of, or refusal to renew registration

  50-32-312. Procedure for denial, suspension, revocation of, or refusal to renew registration. (1) Before denying, suspending, or revoking a registration or refusing a renewal of registration, the board shall serve upon the applicant or registrant an order to show cause why registration should not be denied, revoked, or suspended or why the renewal should not be refused. The order to show cause shall contain a statement of the basis therefor and shall require the applicant or registrant to appear before the board at a time and place not less than 30 days after the date of service of the order, but in the case of a denial of renewal of registration, the show cause order shall be served not later than 30 days before the expiration of the registration. These proceedings shall be conducted without regard to any criminal prosecution or other proceeding. Proceedings to refuse renewal of registration do not abate the existing registration, which remains in effect pending the outcome of the administrative hearing.   (2) The board may suspend, without an order to show cause, any registration simultaneously with the institution of proceedings under 50-32-311 or whenever renewal of registration is refused if it finds that there is an imminent danger to the public health or safety which warrants such action. The suspension continues in effect until the conclusion of the proceedings, including judicial review thereof, unless sooner withdrawn by the board or dissolved by a court of competent jurisdiction.   History: En. Sec. 19, Ch. 412, L. 1973; amd. Sec. 9, Ch. 350, L. 1974; amd. Sec. 7, Ch. 187, L. 1977; R.C.M. 1947, 54-319.
MT Code § 50-32-313 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-313. Practitioner's failure to register a misdemeanor

  50-32-313. Practitioner's failure to register a misdemeanor. Practitioners who fail or refuse to register as required by this chapter shall be guilty of a misdemeanor and upon conviction therefor may be fined not to exceed $1,000, imprisoned in the county jail not to exceed 1 year, or both.   History: En. Sec. 29, Ch. 412, L. 1973; R.C.M. 1947, 54-327.
MT Code § 50-32-314 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 3. Annual Registration|50-32-314. Board to adopt rules for registration of outpatient center for surgical services

  50-32-314. Board to adopt rules for registration of outpatient center for surgical services. (1) The board shall adopt rules to provide for the registration of any outpatient center for surgical services pursuant to this part. The rules must categorize the outpatient center for surgical services as a "distributor" pursuant to 50-32-101(13) or other category of registrant as determined by the board.   (2) If the board determines that an outpatient center for surgical services requires the services of a pharmacist in order to be registered, the board shall allow that center to use the services of a consulting pharmacist to satisfy the obligation imposed by the board.   (3) This section does not affect any existing registration requirement pursuant to this part for persons providing dangerous drugs to an outpatient center for surgical services or persons administering dangerous drugs within or as the result of procedures performed at an outpatient center for surgical services.   History: En. Sec. 1, Ch. 273, L. 1999; amd. Sec. 42, Ch. 502, L. 2007; amd. Sec. 11, Ch. 135, L. 2013.
MT Code § 50-32-401 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 4. Transfer of Precursors to Controlled Substances|50-32-401. Report required for precursor to controlled substance

  50-32-401. Report required for precursor to controlled substance. (1) A manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any of the following substances to a person in this state shall submit a report to the department of justice detailing all transactions:   (a) phenyl-2-propanone;   (b) methylamine;   (c) d-lysergic acid;   (d) ergotamine tartrate;   (e) diethyl malonate;   (f) malonic acid;   (g) ethyl malonate;   (h) barbituric acid; and   (i) piperidine.   (2) The department of justice may adopt, amend, or repeal rules in accordance with the Montana Administrative Procedure Act that add or delete substances on the list of regulated substances in subsection (1) if the substance is a precursor to a dangerous drug as defined in 50-32-101.   (3) This section does not apply to any of the following:   (a) a pharmacist or other authorized person who sells or furnishes the substance upon the prescription of a physician, dentist, podiatrist, or veterinarian;   (b) a physician, dentist, podiatrist, or veterinarian who administers or furnishes the substance to patients;   (c) a manufacturer or wholesaler licensed by the board of pharmacy who sells, transfers, or otherwise furnishes the substance to a licensed pharmacist, physician, dentist, podiatrist, or veterinarian;   (d) transfers of the substances listed in subsection (1) within any college or university to an employee or student of the college or university for the purpose of teaching or research authorized by the college or university.   History: En. Sec. 1, Ch. 227, L. 1979; amd. Sec. 1, Ch. 247, L. 1983; amd. Sec. 1848, Ch. 56, L. 2009.
MT Code § 50-32-402 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 4. Transfer of Precursors to Controlled Substances|50-32-402. Reports required -- exceptions

  50-32-402. Reports required -- exceptions. (1) Except as provided in subsection (2), a manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any substance regulated pursuant to 50-32-401 to a person in this state must, within 72 hours, submit a report of the transaction to the department of justice.   (2) The department may authorize the submission of the reports on a monthly basis for repeated, regular transactions between the furnisher and the recipient involving the same substance, if the department determines:   (a) a pattern of regular supply of the substance exists as between the manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes the substance and the recipient of the substance; and   (b) the recipient has established a record of use of the substance for lawful purposes.   History: En. Sec. 2, Ch. 227, L. 1979.
MT Code § 50-32-403 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 4. Transfer of Precursors to Controlled Substances|50-32-403. Common reporting form

  50-32-403. Common reporting form. (1) The department of justice must provide a common reporting form for the report required under 50-32-401.   (2) The form must contain the following information:   (a) name of the substance;   (b) quantity of the substance sold, transferred, or furnished;   (c) the date the substance was sold, transferred, or furnished;   (d) the name and address of the person buying or receiving the substance; and   (e) the name and address of the manufacturer, wholesaler, or retailer.   History: En. Sec. 3, Ch. 227, L. 1979.
MT Code § 50-32-404 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 4. Transfer of Precursors to Controlled Substances|50-32-404. Loss, theft, or other discrepancy to be reported

  50-32-404. Loss, theft, or other discrepancy to be reported. (1) The theft or loss of a substance regulated in accordance with 50-32-401 must be reported to the department of justice within 3 days after the theft or loss is discovered.   (2) Any difference between the quantity received of any substance regulated as provided in 50-32-401 and the quantity shipped must be reported to the department of justice within 3 days of the discovery of the discrepancy.   (3) A report made pursuant to this section shall also include the name of the common carrier or person who transported the substance and the date of shipment.   History: En. Sec. 4, Ch. 227, L. 1979.